Literature DB >> 4151077

Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol.

R R Vollmer, I Cavero, R J Ertel, T A Solomon, J P Buckley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4151077     DOI： 10.1111/j.2042-7158.1974.tb09252.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  23 in total

1.  A cannabinoid with cardiovascular activity but no overt behavioral effects.

Authors:  M D Adams; J T Earnhardt; B R Martin; L S Harris; W L Dewey; R K Razdan
Journal:  Experientia       Date:  1977-09-15

2.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Authors:  Z Járai; J A Wagner; K Varga; K D Lake; D R Compton; B R Martin; A M Zimmer; T I Bonner; N E Buckley; E Mezey; R K Razdan; A Zimmer; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Cannabis and the cardiovascular system.

Authors: 
Journal:  Br Med J       Date:  1978-02-25

Review 4.  The endocannabinoid system in cardiovascular function: novel insights and clinical implications.

Authors:  Salvador Sierra; Natasha Luquin; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2017-12-08       Impact factor: 4.435

5.  The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression.

Authors:  Nathalie Niederhoffer; Karin Schmid; Bela Szabo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-23       Impact factor: 3.000

6.  Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats.

Authors:  James R Padley; Qun Li; Paul M Pilowsky; Ann K Goodchild
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

7.  The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat.

Authors:  J D Graham; M J Lewis; D M Li
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

8.  Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.

Authors:  V E Mendizábal; E Adler-Graschinsky
Journal:  Br J Pharmacol       Date:  2007-04-23       Impact factor: 8.739

9.  Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.

Authors:  María del Carmen García; Edda Adler-Graschinsky; Stella Maris Celuch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-18       Impact factor: 3.000

10.  Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Authors:  Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; George Kunos
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.